Phase 3 trials of solanezumab and bapineuzumab for Alzheimer's disease

N Engl J Med. 2014 Apr 10;370(15):1460. doi: 10.1056/NEJMc1402193.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Alzheimer Disease / drug therapy*
  • Amyloid beta-Peptides / antagonists & inhibitors*
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Female
  • Humans
  • Male

Substances

  • Amyloid beta-Peptides
  • Antibodies, Monoclonal, Humanized